Suchergebnisse - "Ponne, Saravanaraman"

PubPharm (17)

1

Reverse engineering protection : A comprehensive survey of reverse vaccinology-based vaccines targeting viral pathogens

enthalten in: Vaccine | 2024

von Ponne, S. | Kumar, R. | Vanmathi, S. | +2

2

Pharmacoinformatic approach to identify potential phytochemicals against SARS-CoV-2 spike receptor-binding domain in native and variants of concern

enthalten in: Molecular diversity | 2023

von Chinnadurai, R. | Ponne, S. | Chitra, L. | +3

3

Current research status of anti-cancer peptides : Mechanism of action, production, and clinical applications

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Chinnadurai, R. | Khan, N. | Meghwanshi, G. | +3

4

Pharmacoinformatic approach to identify potential phytochemicals against SARS-CoV-2 spike receptor-binding domain in native and variants of concern

enthalten in: Molecular diversity | 2022

von Chinnadurai, R. | Ponne, S. | Chitra, L. | +3

5

microRNA-150 targets major epigenetic repressors and inhibits cell proliferation

enthalten in: Experimental cell research | 2022

von Selvam, M. | Bandi, V. | Ponne, S. | +2

6

CREB acts as a common transcription factor for major epigenetic repressors; DNMT3B, EZH2, CUL4B and E2F6

enthalten in: Medical oncology (Northwood, London, England) | 2020

von Ashok, C. | Selvam, M. | Ponne, S. | +3

7

CREB acts as a common transcription factor for major epigenetic repressors; DNMT3B, EZH2, CUL4B and E2F6

enthalten in: Medical oncology | 2020

von Ashok, C. | Selvam, M. | Ponne, S. | +3

8

CREB acts as a common transcription factor for major epigenetic repressors; DNMT3B, EZH2, CUL4B and E2F6

enthalten in: Medical oncology | 2020

von Ashok, C. | Selvam, M. | Ponne, S. | +3

9

Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury - A potential therapeutic agent for Alzheimer's Disease

enthalten in: Metabolic brain disease | 2020

von Ponne, S. | Kumar, C. | Boopathy, R.

10

Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury – A potential therapeutic agent for Alzheimer’s Disease

enthalten in: Metabolic brain disease | 2019

von Ponne, S. | Kumar, C. | Boopathy, R.